5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 49.37▼ | 49.18▼ | 48.73▲ | 48.39▲ | 45.29▲ |
MA10 | 49.45▼ | 48.83▲ | 48.34▲ | 46.64▲ | 44.04▲ |
MA20 | 49.45▼ | 48.34▲ | 48.42▲ | 44.73▲ | 41.97▲ |
MA50 | 48.84▲ | 48.25▲ | 47.66▲ | 43.69▲ | 33.61▲ |
MA100 | 48.53▲ | 47.41▲ | 45.86▲ | 41.71▲ | 30.30▲ |
MA200 | 48.44▲ | 45.58▲ | 44.59▲ | 34.46▲ | 46.35▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.091▼ | 0.107▲ | 0.060▲ | 0.486▲ | 0.088▲ |
RSI | 41.998▼ | 53.401▲ | 54.945▲ | 59.428▲ | 63.732▲ |
STOCH | 47.898 | 57.323 | 36.245 | 81.997▲ | 65.448 |
WILL %R | -91.743▼ | -62.795 | -62.795 | -33.320 | -22.450▲ |
CCI | -238.126▼ | 37.176 | 77.636 | 132.321▲ | 158.515▲ |
Thursday, May 01, 2025 01:33 PM
Guardant Health exceeds Q1 expectations, boosts growth outlook, and gains from favorable pricing and approvals. Read more about GH stock here.
|
Thursday, May 01, 2025 12:18 AM
Guardant Health Inc (GH) reports a 21% revenue increase, strategic partnership with Pfizer, and raised full-year guidance despite ongoing challenges.
|
Thursday, May 01, 2025 12:18 AM
Guardant Health Inc (GH) reports a 21% revenue increase, strategic partnership with Pfizer, and raised full-year guidance despite ongoing challenges.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 52.645 | 52.92 | 47.09 | 48.87 | 5,049,991 |
30/04/25 | 47.73 | 48.41 | 46.76 | 47.23 | 3,567,369 |
29/04/25 | 47.655 | 50.20 | 47.63 | 49.58 | 1,955,574 |
28/04/25 | 48.77 | 49.86 | 47.36 | 47.99 | 1,728,378 |
25/04/25 | 46.85 | 48.35 | 46.39 | 48.30 | 1,405,367 |
24/04/25 | 46.06 | 47.60 | 44.50 | 47.41 | 1,739,727 |
23/04/25 | 45.75 | 47.71 | 45.42 | 45.64 | 2,317,069 |
22/04/25 | 43.45 | 45.14 | 43.31 | 43.80 | 1,775,426 |
21/04/25 | 44.31 | 44.97 | 41.8503 | 42.61 | 2,133,742 |
17/04/25 | 44.79 | 45.11 | 43.94 | 44.97 | 1,843,912 |
|
|
||||
|
|
||||
|
|